M James Frates

Affiliations

  • at Sage Therapeutics Inc. (SAGE), 2025-06-13
  • Chief Financial Officer at Amylyx Pharmaceuticals Inc. (AMLX), 2025-04-02
  • Svp, Alks Inc; Cfo Alks at Alkermes Plc. (ALKS), 2020-05-14
  • Svp, Cfo & Treasurer at Alkermes Inc (ALKS), 2011-09-20
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AMLX $2.53 40,000 $101,368.00 233,464 2024-09-12 Filing
SAGE $55.10 1,810 $99,734.62 1,810 2021-06-16 Filing
SAGE $18.00 5,000 $90,000.00 5,000 2014-07-23 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AMLX $3.47 10,896 $37,805.85 290,988 2025-03-31 Filing
AMLX $18.73 1,792 $33,560.40 134,784 2024-03-05 Filing
AMLX $16.33 2,716 $44,347.12 112,035 2024-01-09 Filing
AMLX $27.60 500 $13,800.00 55,676 2023-05-16 Filing
AMLX $26.93 32,000 $861,651.20 56,176 2023-05-16 Filing